Allakos Inc. (ALLK)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

3.0000

-0.0200

(-0.66%)

At close: 04:00PM EDT

2.8700

-0.13

(-4.33%)

After hours:

07:30PM EDT

Loading interactive chart...

GlobeNewswire
Allakos Provides Business Update and Reports First Quarter 2022 Financial Results
REDWOOD CITY, Calif., May 06, 2022 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing lirentelimab (AK002) and AK006 for the treatment of allergic and inflammatory diseases, today provided a business update and reported financial results for the first quarter ended March 31, 2022. Recent Events Initiated a Phase 2 randomized, double-blind, placebo-controlled study of subcutaneous lirentelimab in patients with moderate-to-severe atopic dermatitis i
Zacks
Allakos Inc. (ALLK) Stock Sinks As Market Gains: What You Should Know
Allakos Inc. (ALLK) closed at $3.86 in the latest trading session, marking a -1.03% move from the prior day.
Zacks
Allakos Inc. (ALLK) Gains As Market Dips: What You Should Know
In the latest trading session, Allakos Inc. (ALLK) closed at $5.46, marking a +0.18% move from the previous day.